| Not Yet Recruiting | BETWEEN: Biweekly Bevacizumab + Trifluridine/Tipiracil to Reduce Grade 3-4 Neutropenia in mCRC Patients Metastatic Colorectal Cancer | Phase 2 | 2025-09-01 |
| Not Yet Recruiting | Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study Colon Cancer | Phase 2 | 2025-09-01 |
| Not Yet Recruiting | PANORAMIX : Optimizing 1st-line NALIRIFOX and Exploring Microbiota's Role in 2nd Line Pancreatic Cancer Treatm PDAC - Pancreatic Ductal Adenocarcinoma | Phase 2 | 2025-07-01 |
| Active Not Recruiting | POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreat Pancreatic Ductal Adenocarcinoma, Esophageal Cancer | N/A | 2024-06-24 |
| Recruiting | First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer Gastric Cancer | Phase 2 | 2024-04-16 |
| Recruiting | ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases Metastatic Colorectal Cancer, Circulating Tumor DNA | — | 2024-01-09 |
| Recruiting | Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study Adenocarcinoma - GEJ, Gastric Adenocarcinoma | Phase 2 | 2023-12-18 |
| Recruiting | Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients Colorectal Cancer, Liver Cancer, Gastric Cancer | N/A | 2023-11-22 |
| Withdrawn | Combined Neuromuscular Electrical Stimulation and Nutritional Support for Advanced Gastrointestinal Cancer Pat Cancer Digestive | N/A | 2023-09-01 |
| Recruiting | Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL S Biliary Tract Cancer | — | 2022-05-23 |
| Recruiting | Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC Metastatic Colorectal Cancer | Phase 2 | 2022-05-05 |
| Terminated | Cardiovascular Events From Trifluridine/Tipiracil +/- Oxaliplatin in Colorectal/Oesogastric Adenocarcinoma Pat Colorectal Adenocarcinoma, Oesogastric | Phase 2 | 2022-02-07 |
| Active Not Recruiting | Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. Colorectal Cancer Metastatic, MSI-H Colorectal Cancer | Phase 2 | 2021-05-21 |
| Active Not Recruiting | OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDA Pancreatic Ductal Adenocarcinoma, Locally Advanced Cancer, Metastatic Cancer | Phase 2 | 2021-04-10 |
| Recruiting | Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carci Neuroendocrine Carcinoma, Digestive Cancer | Phase 2 | 2021-01-05 |
| Active Not Recruiting | Maintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and KRAS Status. Metastatic Pancreatic Adenocarcinoma | Phase 2 | 2020-12-07 |
| Active Not Recruiting | LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy Metastatic Colorectal Cancer | Phase 2 | 2020-05-20 |
| Active Not Recruiting | Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenoc Localized Oesogastric Adenocarcimona, MSI and or dMMR | Phase 2 | 2019-10-23 |
| Active Not Recruiting | QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters. Elderly Patients, Metastatic Colorectal Cancer, Quality of Life | Phase 3 | 2019-06-14 |
| Active Not Recruiting | Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy. Advanced Biliary Tract Carcinoma | Phase 2 | 2018-11-09 |
| Completed | A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma Anal Cancer | Phase 2 | 2018-07-03 |
| Active Not Recruiting | iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipili Metastatic Cancer Colorectal | Phase 2 | 2017-12-04 |
| Unknown | Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Colorectal Cancer, Stage III Colon Cancer | — | 2017-07-13 |
| Active Not Recruiting | Management of Symptomatic Advanced Pancreatic Adenocarcinoma Pancreas, Management Supportive Care Program | N/A | 2016-12-19 |
| Completed | Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metast Metastatic Colorectal Cancer | Phase 2 | 2016-02-01 |
| Completed | A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer Unresectable Advanced Cancer | Phase 1 | 2015-11-18 |
| Terminated | Rechallenge of Cetuximab Combined With Irinotecan as Third-line Chemotherapy in Patients With Metastatic Color Colorectal Cancer Metastatic | Phase 2 | 2015-09-23 |
| Terminated | Metabolic Radiotherapy After Complete Resection of Liver Metastases in Patient With Digestive Neuroendocrine T Digestive Neuroendocrine Tumors, Metabolic Radiotherapy, Resection | Phase 3 | 2015-09-01 |
| Unknown | NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma Cancer of Stomach | Phase 2 | 2015-06-01 |
| Completed | Follow up to the AVANT Study up to 8 and 10 Years (Median Follow up) in Patients With Colon Carcinoma Colon Cancer Treated With Bevacizumab After Colon Surgery | — | 2015-03-01 |
| Unknown | Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer Unresectable Locally Advanced Cancer, Metastatic Pancreatic Cancer | N/A | 2014-11-20 |
| Unknown | Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic C Metastatic Pancreatic Cancer | Phase 2 | 2013-12-12 |
| Unknown | Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer Colorectal Cancer Metastatic | Phase 3 | 2013-10-30 |
| Completed | OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal Cancer Unresectable Metastatic Colorectal Cancer | Phase 2 | 2013-05-01 |
| Unknown | A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metas Carcinoid Tumors | Phase 2 | 2013-01-07 |
| Completed | A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma Unresectable and Advanced Cholangiocarcinoma | Phase 2 | 2011-09-01 |
| Terminated | Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluo Colorectal Cancer | Phase 2 | 2011-05-01 |
| Unknown | Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery Liver Cancer | Phase 2 | 2010-05-01 |
| Completed | Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Sur Head and Neck Cancer | Phase 1 / Phase 2 | 2009-10-01 |
| Unknown | Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer Colorectal Cancer | Phase 3 | 2009-05-12 |
| Completed | Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2008-06-01 |
| Completed | Combination Chemotherapy in Treating Older Patients With Solid Tumour, Solid Tumor Regardless of Localization and Stage | Phase 4 | 2008-03-01 |
| Completed | Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Pancreatic Cancer | Phase 3 | 2008-02-01 |
| Completed | Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer Head and Neck Cancer | Phase 2 | 2008-02-01 |
| Terminated | Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer Chemotherapeutic Agent Toxicity, Pancreatic Cancer, Thromboembolism | Phase 3 | 2007-10-01 |
| Unknown | Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin Cancer | Phase 4 | 2005-10-01 |
| Unknown | Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | 2005-08-01 |
| Completed | Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cance Colorectal Cancer | Phase 2 | 2005-08-01 |
| Completed | Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients Colorectal Cancer | Phase 3 | 2005-05-01 |
| Unknown | Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 3 | 2004-09-01 |
| Unknown | Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage Lung Cancer | Phase 2 | 2004-05-01 |
| Unknown | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surg Colorectal Cancer | Phase 2 / Phase 3 | 2004-01-01 |
| Unknown | Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Cancer | Phase 3 | 2003-11-01 |
| Unknown | Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients Pancreatic Cancer | Phase 2 | 2003-11-01 |
| Unknown | Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | Phase 2 | 2003-10-01 |
| Unknown | Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Canc Lung Cancer | Phase 2 | 2003-09-01 |
| Unknown | Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2003-09-01 |
| Unknown | Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer Ovarian Cancer | Phase 1 / Phase 2 | 2003-07-01 |
| Recruiting | Prognostic and Predictive Markers of Treatment Response in Patients With PAC. Pancreatic Adenocarcinoma | — | 2003-01-01 |
| Completed | Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases Colorectal Cancer, Metastatic Cancer, Chemotherapy | Phase 3 | 2002-07-01 |
| Unknown | Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresect Colorectal Cancer | Phase 2 | 2002-06-01 |
| Unknown | Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Lung Cancer | Phase 3 | 2002-06-01 |
| Unknown | Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Aden Colorectal Cancer | Phase 2 | 2002-01-01 |
| Unknown | Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenoc Gastric Cancer | Phase 2 | 2001-04-01 |
| Unknown | Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2000-10-01 |
| Unknown | Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer Breast Cancer | Phase 2 | 2000-05-01 |
| Unknown | Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 3 | 2000-01-01 |
| Unknown | Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer Breast Cancer | Phase 2 | 2000-01-01 |
| Unknown | Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 2 | 1999-09-01 |
| Unknown | Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III C Esophageal Cancer | Phase 1 / Phase 2 | 1999-08-01 |
| Unknown | Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastat Bladder Cancer | Phase 2 | 1999-07-01 |
| Unknown | Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormon Prostate Cancer | Phase 2 | 1999-05-01 |
| Unknown | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 1999-04-01 |
| Unknown | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 1999-04-01 |
| Unknown | Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct Extrahepatic Bile Duct Cancer, Pancreatic Cancer | Phase 2 | 1999-01-01 |
| Unknown | Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer Colorectal Cancer | Phase 3 | 1998-01-01 |